VA Disability Rating for Benign neoplasms of the eye, orbit, and adnexa (DC 6015)

Body system: EyeRegulation: 38 CFR § 4.79DBQ: DBQ OPHTH Eyes

DC 6015 covers benign (non-cancerous) growths of the eye, orbit and adnexa, excluding the skin. The regulation does not give the code its own percentages: it is rated on the visual impairment the growth causes under the General Rating Formula for Diseases of the Eye (38 CFR 4.79), and any nonvisual impairment, such as disfigurement, is rated separately under the appropriate code.

Rating levels

  • Note — Benign (non-cancerous) growths of the eye, orbit (eye socket), or adnexa (surrounding structures including the eyelids, tear ducts, and conjunctiva) are rated under 38 CFR § 4.79 based on any resulting visual impairment, or by analogy to disfigurement (DC 7800) when the growth produces visible disfigurement of the face.

Disclaimer: This tool is for informational purposes only and is not legal or medical advice. Always consult with your VSO representative or a qualified veterans benefits attorney for guidance on your specific claim.

Choroidopathy, including uveitis, iritis, cyclitis, or choroiditis (DC 6000)
The plain-English rating criteria and Board decision data for DC 6000.
Keratopathy (DC 6001)
The plain-English rating criteria and Board decision data for DC 6001.
Scleritis (DC 6002)
The plain-English rating criteria and Board decision data for DC 6002.
Retinopathy or maculopathy not otherwise specified (DC 6006)
The plain-English rating criteria and Board decision data for DC 6006.
Intraocular hemorrhage (DC 6007)
The plain-English rating criteria and Board decision data for DC 6007.